0001209191-16-093101.txt : 20160122
0001209191-16-093101.hdr.sgml : 20160122
20160122161035
ACCESSION NUMBER: 0001209191-16-093101
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160120
FILED AS OF DATE: 20160122
DATE AS OF CHANGE: 20160122
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACHILLION PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001070336
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 GEORGE STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
BUSINESS PHONE: 203-624-7000
MAIL ADDRESS:
STREET 1: 300 GEORGE STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Apelian David
CENTRAL INDEX KEY: 0001546842
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33095
FILM NUMBER: 161356336
MAIL ADDRESS:
STREET 1: C/O ACHILLION PHARMACEUTICALS, INC
STREET 2: 300 GEORGE STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-01-20
0
0001070336
ACHILLION PHARMACEUTICALS INC
ACHN
0001546842
Apelian David
C/O ACHILLION PHARMACEUTICALS, INC.
300 GEORGE STREET
NEW HAVEN
CT
06511
0
1
0
0
Chief Medical Officer
Employee Stock Option
7.61
2016-01-20
4
A
0
118000
0.00
A
2026-01-20
Common Stock
118000
118000
D
This option vests as to 25% of the original number of shares on the first anniversary of the grant date and as to an additional 6.25% of the original number of shares at the end of each successive three-month period following the first anniversary of the grant date until the fourth anniversary of the grant date.
/s/ Mary Kay Fenton, attorney-in-fact
2016-01-22